Literatur
Post F, Mertens D, Peetz D, Weilemann LS, Münzel T (2006) Levosimedan bei der Therapie der akuten hämodynamisch bedeutsamen Lungenembolie. Intensivmed 43:636–642
Binder L, Pieske B, Olschewski M, Geibel A, Klostermann B, Reiner C, Konstantinides S (2005) N-terminal pro-brain natriuretic peptide of troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 112:1573–1579
Meyer G, Sors H, Charbonnier B, Kasper W, Bassand J-P, Kerr ICH, Lessaffre E, Vanhove P, Verstrete M (1992) Effects of urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a european multicenter double-blind trial. J Am Coll Cardiol 19:239–245
Tebbe U, Graf A, Kamke W, Zahn R, Forycki F, Kratzsch G, Berg G (1999) Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Am Heart J 138:39–44
Wood KE (2002) Major pulmonary embolism. Review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 121:877–905
Leather HA, Ver Eycken K, Segers P, (2003) Effects of levosimedan on right ventricular function and ventriculovascular coupling in open chest pigs. Crit Care Med 31:2339–2343
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Janata, K., Laggner, A.N. Levosimedan bei der Therapie der akuten hämodynamisch bedeutsamen Lungenembolie. Intensivmed 44, 52 (2007). https://doi.org/10.1007/s00390-007-0776-8
Issue Date:
DOI: https://doi.org/10.1007/s00390-007-0776-8